As demonstrated in Figure 1e and f, the USP8 inhibitor DUB-IN-1 effectively reduced the percentages of cells with positive Ki-67 staining, suggesting a growth-suppressive influence of USP8 inhibition on these glioma cells. Here, USP8 is linked to central nervous system cancer.